KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Castle Biosciences (CSTL) over the last 7 years, with Q3 2025 value amounting to 0.07%.

  • Castle Biosciences' Return on Capital Employed fell 700.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.02% for FY2024, which is 1900.0% up from last year.
  • As of Q3 2025, Castle Biosciences' Return on Capital Employed stood at 0.07%, which was down 700.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Return on Capital Employed registered a high of 0.02% during Q4 2024, and its lowest value of 0.25% during Q2 2023.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.09% (2021), whereas its average is 0.1%.
  • In the last 5 years, Castle Biosciences' Return on Capital Employed plummeted by -1200bps in 2022 and then surged by 2100bps in 2024.
  • Castle Biosciences' Return on Capital Employed (Quarter) stood at 0.09% in 2021, then crashed by -85bps to 0.17% in 2022, then grew by 2bps to 0.17% in 2023, then skyrocketed by 111bps to 0.02% in 2024, then tumbled by -483bps to 0.07% in 2025.
  • Its Return on Capital Employed was 0.07% in Q3 2025, compared to 0.05% in Q2 2025 and 0.03% in Q1 2025.